The Syphilis Testing Market is projected to attain $3.6 Billion by 2020, growing at a CAGR of 1.2% during the forecast period, 2015-2020.
Get the Sample Report @ https://www.alliedmarketresearch.com/request-sample/675
Rising Syphilis cases remain a vital public health issue and are a significant concern across the globe, especially in developing economies. The rising burden of syphilis incidences and implementation of national screening programs are major factors fueling the growth of Syphilis testing worldwide. Furthermore, the growing adoption of novel technologies such as Enzyme Immunoassay (EIA) tests, Darkfield microscopy, and Microhemagglutination (MHA-TP) assay enables faster and improved screening results – thus provides an additional boost to the market growth.
The surge of syphilis incidence and prevalence rates, implementation of national screening programs, and reimbursement policies for syphilis testing drive the growth of the global syphilis testing market. Additionally, the decreasing number of visits to GUM clinics & specialized STD clinics, surge in the number of national screening programs worldwide, niche technological advancements, and the availability of POC testing services in developing countries provide lucrative opportunities for new market players. However, the social stigma associated with visiting specialized STD clinics, a huge population of patients infected with syphilis in remote locations, and harsh regulatory abidance requirements for key players restrain market growth.
The report segments the global syphilis testing market by types and geography. Based on types, the report bifurcates the market into primary syphilis and secondary syphilis. Regionally, Asia-Pacific and LAMEA constitute the two largest regions for syphilis testing market and collectively accounted for about 4/5th of the global revenue in 2014. The growth of the market in these regions is supplemented by higher adoption rates for technologically advanced screening tests methods, active measures from governments & private associations, and growing awareness of syphilis infections.
Also, rising incidences of syphilis due to men having sex with men (MSM) and implementation of mandatory screening tests for all pregnant women would further foster the growth of syphilis testing market in these regions. While China and India collectively account for about 89% share in the Asia-Pacific syphilis testing market, United States remains a major market in the North America syphilis testing market through 2020.
For Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/675
The report also profiles key players involved in the global syphilis testing market, such as
- Roche Diagnostics
- Hologic, Inc.,
- Becton Dickinson & Company,
- Abbott Laboratories,
- Alere Inc.,
- Cepheid Inc.,
- Affymetrix, Inc.,
They have adopted various strategies such as mergers & acquisitions, collaborations, partnerships, and others to gain a strong position in the industry.
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060